ARQT vs MLM · rev $196.5M vs P/E 36, rev $6.15B
Arcutis Biotherapeutics Inc (ARQT) versus Martin Marietta Materials Inc (MLM) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Martin Marietta Materials Inc (MLM) is a building materials company listed on US.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported MLM revenue for 2025-12-31 was $6.15B. Net income was $1.14B. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
ARQT currently screens at market cap $1.64B. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
Not investment advice. Open the ARQT and MLM stock pages for the full models.
Not investment advice.